Loading…
Simulations Plus, Inc. is projected to rise to $22.17 by 2027, a +21% move from its current price of $18.34. SLP is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $17.96 | $18.35 | $18.75 | +0.07% |
| Jul 14 | $17.82 | $18.37 | $18.93 | +0.14% |
| Jul 15 | $17.71 | $18.38 | $19.07 | +0.21% |
| Jul 16 | $17.62 | $18.39 | $19.20 | +0.28% |
| Jul 17 | $17.54 | $18.40 | $19.31 | +0.35% |
| Jul 18 | $17.47 | $18.42 | $19.41 | +0.42% |
| Jul 19 | $17.41 | $18.43 | $19.51 | +0.49% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.41 | $18.43 | $19.51 | +0.49% |
| Week 2 | $17.09 | $18.52 | $20.07 | +0.98% |
| Week 3 | $16.87 | $18.61 | $20.53 | +1.48% |
| Week 4 | $16.69 | $18.70 | $20.95 | +1.97% |
| Week 5 | $16.55 | $18.79 | $21.34 | +2.47% |
| Week 6 | $16.43 | $18.89 | $21.70 | +2.97% |
| Week 7 | $16.33 | $18.98 | $22.05 | +3.48% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments and offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products.
It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. Additionally, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems.
Simulations Plus serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Simulations Plus, Inc. (SLP) is a healthcare company trading at a current price of $18.24, with a market cap of $368.55M and a market rank of 3280.
The forecast outlook shows a long-term bullish trajectory, with the average price rising across key milestones: 2026 avg $18.24 (max $24.76), 2030 avg $30.17 (max $46.48), 2040 avg $73.00 (max $134.42), and 2050 avg $168.18 (max $343.99). These figures point to meaningful upside potential over the next decades.
The multi-year view carries bullish sentiment from 2029 onward, with 2029 (avg $26.09, min $18.86, max $39.03) labeled as BULLISH and continuing bullish into 2030, 2040, and 2050, with corresponding avg prices and strong max forecasts. The implied price path suggests substantial upside relative to the current level.
A major floor 38.1% below — a decisive break under it would weaken the trend.
The nearest floor, 13.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.3% away) — a breakout level to watch.
A major ceiling 9.1% above — clearing it would confirm fresh momentum.
Key SLP support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SLP market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $18.30 | Buy | $18.29 | Buy |
| MA 10 | $18.31 | Buy | $18.22 | Buy |
| MA 20 | $17.98 | Buy | $17.85 | Buy |
| MA 50 | $16.39 | Buy | $16.69 | Buy |
| MA 100 | $14.52 | Buy | $16.00 | Buy |
| MA 200 | $15.96 | Buy | $16.82 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.90 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | 36.50 | Neutral |
| Williams %R (14) | -51.72 | Info |
| MACD (12,26,9) | -0.09 | Sell |
| ROC (12) | 0.50 | Buy |
| Bollinger %B (20,2) | 0.60 | Neutral |
| Stochastic %K (14) | 48.28 | Neutral |
| TRIX (15) | 0.60 | Buy |
| Awesome (5,34) | 1.07 | Buy |
| Ultimate (7,14,28) | 45.71 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 18.27 | Buy |
| ADX (14) | 29.06 | Buy |
| ATR (14) | 0.19 | Info |
The 30-day technical picture shows a bullish tilt, with RSI(14) at 70, suggesting momentum is strong and near overbought levels. The stock is trading above both the SMA50 ($15.05) and the SMA200 ($15.67), indicating a positive short-term trend.
The 30-day range spans $14.48 to $22.98, with nearby support at $13.34 and resistance at $18.24. The combination of bullish sentiment and the current price action above major moving averages points to continued strength in the near term, albeit with elevated volatility as indicated by an annualized volatility of 70%.
Overall, the near-term setup favors continued upside potential while acknowledging the risk implied by high volatility and momentum measures.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.36 | $18.34 | $24.27 | 0% | Neutral | |
| $18.00 | $22.17 | $28.66 | +21% | Bullish | |
| $19.23 | $24.19 | $32.23 | +32% | Bullish | |
| $23.78 | $30.46 | $41.54 | +66% | Bullish | |
| $28.42 | $36.97 | $51.44 | +102% | Bullish | |
| $32.13 | $42.38 | $60.00 | +131% | Bullish | |
| $36.75 | $49.12 | $70.65 | +168% | Bullish | |
| $38.68 | $52.32 | $76.34 | +185% | Bullish | |
| $40.68 | $55.66 | $82.29 | +204% | Bullish | |
| $43.99 | $60.86 | $91.08 | +232% | Bullish | |
| $69.99 | $101.73 | $160.33 | +455% | Bullish | |
| $152.54 | $240.84 | $409.65 | +12.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.36 | $18.34 | $21.77 | +0.00% |
| August 2026 | $16.02 | $18.80 | $22.58 | +2.50% |
| September 2026 | $16.56 | $19.54 | $23.68 | +3.97% |
| October 2026 | $16.56 | $19.63 | $23.97 | +0.45% |
| November 2026 | $16.28 | $19.38 | $23.80 | -1.31% |
| December 2026 | $16.45 | $19.65 | $24.27 | +1.41% |
Click any year to see its month-by-month SLP forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SLP is projected to trade between $11.36 and $24.27, averaging $18.34 — a potential gain of 0% from today's $18.34. Price action looks broadly range-bound.
Simulations Plus, Inc.'s 2027 outlook centres on $22.17, within a $18.00 to $28.66 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, SLP could reach as high as $32.23, with a base case around $24.19 and support toward $19.23 — roughly +32% from $18.34. Momentum favours further upside here.
Expect SLP to range from $23.78 to $41.54 through 2029. The $30.46 average target implies a +66% move from current prices. That is up +26% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The SLP price prediction for 2030 points to an average of $36.97 (low $28.42, high $51.44) — a potential gain of +102% on today's $18.34. Momentum favours further upside here.
In 2031, SLP is projected to trade between $32.13 and $60.00, averaging $42.38 — a potential gain of +131% from today's $18.34. That is up +15% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Simulations Plus, Inc.'s 2032 outlook centres on $49.12, within a $36.75 to $70.65 range. That is up +16% on the projected 2031 average. That marks a +168% change versus current levels. Momentum favours further upside here.
By 2033, SLP could reach as high as $76.34, with a base case around $52.32 and support toward $38.68 — roughly +185% from $18.34. Buyers look set to stay in control over this stretch.
Expect SLP to range from $40.68 to $82.29 through 2034. The $55.66 average target implies a +204% move from current prices. That is up +6% on the projected 2033 average. Momentum favours further upside here.
The SLP price prediction for 2035 points to an average of $60.86 (low $43.99, high $91.08) — a potential gain of +232% on today's $18.34. Buyers look set to stay in control over this stretch.
In 2040, SLP is projected to trade between $69.99 and $160.33, averaging $101.73 — a potential gain of +455% from today's $18.34. That is up +67% on the projected 2035 average. Momentum favours further upside here.
Simulations Plus, Inc.'s 2050 outlook centres on $240.84, within a $152.54 to $409.65 range. That is up +137% on the projected 2040 average. That marks a +12.1x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SLP today (≈ 54.525627 SLP) could be worth
$13,131.99
+$12,131.99 (+1213%) by 2050 · US Dollar
Based on the average projected SLP price of $240.84 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SLPwould be worth at today's price.
$1,000 invested in SLP on Jul 10, 2025 (≈ 56.915197 SLP) would be worth
$1,043.82
+$43.82 (+4.4%) today · 1.04× · US Dollar
Based on a SLP entry price of $17.57 vs. today's $18.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $18.39 | $997.28 | -0.3% |
| 1 month ago | $15.94 | $1,150.56 | +15.1% |
| 3 months ago | $13.04 | $1,406.44 | +40.6% |
| 6 months ago | $18.91 | $969.86 | -3.0% |
| 1 year ago | $17.57 | $1,043.82 | +4.4% |
| All time (5.0y) ago | $44.03 | $416.53 | -58.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SLP forecast.
Our base-case forecast reaches $37.00 around 2031.
Implied market cap at $37.00: $748.32M
Looking further out, the forecast shows a pronounced upside path with clear milestones. By 2030, the average price is forecast at $30.17 with a 65.4% ROI, and a bullish sentiment accompanies the move. By 2040, the average price rises to $73.00 with a 300.2% ROI, continuing the bullish trend.
By 2050, the average price is forecast at $168.18 with an 822.1% ROI, again described as bullish. The 2050 maximum is projected at $343.99, underscoring substantial long-term upside potential. These figures come with the caveat that they are estimates and not guarantees, and that sentiment shifts toward bullish in the later years as shown in the forecast sequence.
In sum, the multi-year outlook points to a sustained uptrend with meaningful upside potential through 2030, 2040, and 2050, while acknowledging that real-world outcomes depend on market conditions and execution risks.
Tap a question to reveal the answer.
In 2030, the forecast average price is $30.17 with a 65.4% ROI. The 2030 min and max are $21.22 and $46.48 respectively.
The outlook shifts to bullish from 2029 onward, with rising average prices: 2029 avg $26.09 (ROI 43%), 2030 avg $30.17 (ROI 65.4%), 2040 avg $73.00 (ROI 300.2%), and 2050 avg $168.18 (ROI 822.1%). These are estimates, not guarantees.
The forecast maximum for 2050 is $343.99, indicating potential upside under the projected path but not a guarantee.
Current price is $18.24. The 30-day range is $14.48 to $22.98, with support at $13.34 and resistance at $18.24. RSI(14) is 70, and price is above the SMA50 ($15.05) and SMA200 ($15.67), signaling a bullish near-term trend.
Market cap is $368.55M and the rank is 3280.
Simulations Plus, Inc. Community Discussion
0Share your Simulations Plus, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.